Analysis of Modified BIG Scores and Platelet Inhibition in Patients with Traumatic Brain Injuries
The American Surgeon™ · 2026
DOI: 10.1177/00031348251363523 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, 2026. Verfasst von Hunter W Parmer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Tennessee College of Medicine Chattanooga, TN, USA. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Intracranial Hemorrhages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Platelet inhibition is known to occur after traumatic brain injury (TBI) and is predictive of bleed progression. The relationship between platelet inhibition and modified brain injury guideline (mBIG) score, however, is unknown. We hypothesize that patients with higher mBIG scores are more likely to have platelet inhibition and bleed progression.
Methods
A practice management guideline was established calling for a thromboelastography with platelet mapping (TEG-PM) on all adult trauma patients with an intracranial hemorrhage. Patients were then categorized per the mBIG as 1, 2, or 3. Data was retrospectively collected from December 2019 to December 2021. Patients were considered to have platelet inhibition if the percent arachidonic acid (AA) or percent adenosine diphosphate (ADP) inhibition was ≥60% on TEG-PM.
Results
Between December 2019 and December 2021, 768 patients underwent TEG-PM. AA inhibition was more likely to occur in mBIG 3 patients (26.3%) compared to mBIG 1 or mBIG 2 patients ( P = 0.08),. ADP and combined AA/ADP inhibition were similar between mBIG scores. Modified BIG 3 patients were more likely to experience bleed progression compared to mBIG 1 or 2 (46.4%; P < 0.001) and to require neurosurgical intervention (16.5%; p < 0.001).
Discussion
Our study suggests that the higher the mBIG scores, the more likely patients will have worse outcomes regardless of platelet inhibition. Patients with TBI who experience worse outcomes is multifactorial in nature. TEG-PM should be used in conjunction with clinical judgement for treatment guidance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Tennessee College of Medicine Chattanooga, TN, USA.
- Erlanger Health System, Chattanooga, TN, USA.
- Department of Mathematics, University of Tennessee Chattanooga, TN, USA.
- University of Tennessee College of Medicine, Memphis, TN, USA.
ORCID-Profile: Hunter W Parmer
Zitieren
APA
Parmer, H. W., Miles, M. V. P., Hicks, C., Favors, L. E., Rippy, M., Wilson, A., Edwards, A., Stewart, K., & Maxwell, R. A. (2026). Analysis of Modified BIG Scores and Platelet Inhibition in Patients with Traumatic Brain Injuries. The American Surgeon™. https://doi.org/10.1177/00031348251363523
Vancouver
Parmer HW, Miles MVP, Hicks C, Favors LE, Rippy M, Wilson A, et al. Analysis of Modified BIG Scores and Platelet Inhibition in Patients with Traumatic Brain Injuries. The American Surgeon™. 2026. doi:10.1177/00031348251363523
BibTeX
@article{Parmer2026,
author = {Parmer, Hunter W and Miles, M Victoria P and Hicks, Chace and Favors, Lauren E and Rippy, Meredith and Wilson, Andrew and Edwards, Abigail and Stewart, Kathryn and Maxwell, Robert A},
title = {Analysis of Modified BIG Scores and Platelet Inhibition in Patients with Traumatic Brain Injuries},
journal = {The American Surgeon™},
year = {2026},
doi = {10.1177/00031348251363523}
}
EUVIMED